Dear Colleagues:
I am pleased to announce that the Sheiner Rowland Advanced Course in Pharmacokinetics & Pharmacodynamics will be held in Seoul, Korea, on 7-11 September, 2009. This is the second meeting in 2009 in this Course, following that in Washington, D.C., in May 3-8, and the lecturers and the contents will be the same. For those of you who were not able to attend the course in D.C. are urged to consider this one. The course description and registration details are found at http://www.srpkpd.or.kr <http://www.srpkpd.or.kr/> THE SHEINER ROWLAND ADVANCED COURSE IN PHARMACOKINETICS & PHARMACODYNAMICS Dates: Monday, September 7 - Friday, September 11, 2009 Yonsei University Health System, 134 Shinchon-dong, Seodaemun-gu, Seoul, Korea A Workshop, presenting advanced aspects and applications of pharmacokinetics, pharmacodynamics and kinetic/dynamic data analysis in the medical and pharmaceutical sciences. For whom intended: The Workshop is designed for those who have a good working knowledge of basic concepts in pharmacokinetics, pharmacodynamics and data analysis and who now wish to extend their knowledge further. Emphasis will be placed on relating pharmacokinetics to underlying physiological processes and to pharmacodynamics, and on the analysis and modelling of pharmacokinetic and pharmacodynamic data. Workshop content: The mornings will be devoted to lectures; the afternoons to small-group workshops led by experienced tutors, in which participants will solve practical problems and develop facility with the techniques and approaches discussed in the lectures. The participants are encouraged to raise questions from their experience for discussion: time is specifically reserved for such informal discussions. Workshop manual: A course manual, comprising lecture outlines, derivations, problem sets with answers, and additional reading material will be provided. Participants should come with a scientific hand calculator. Topics to be covered include: Empirical models for pharmacokinetics and pharmacodynamics Mechanistic models for pharmacokinetics (compartmental, physiological) and pharmacodynamics (receptor theory) and combined PKPD (immediate and delayed effects) Data analysis techniques for empirical or mechanistic modeling: point estimates, confidence intervals, hypothesis tests. Population pharmacokinetics and pharmacodynamics. Disease progress and drug action modeling Optimal design I hope to see you in Seoul. Sincerely, Kyungsoo Park, PhD, MD Associate Professor of Pharmacology Head of Clinical Trial Development, Clinical Trials Center Yonsei University College of Medicine 134 Shinchon-Dong, Seoul 120-752, Korea Tel: +82-2-2228-1735 / Fax: +82-2-313-1894
<<image001.gif>>
